Drug intelligence / Profile preview

sulfachlorpyridazine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Sulfachlorpyridazine is a synthetic small molecule belonging to the sulfonamide class of antibiotics. It acts as a broad-spectrum antibacterial agent, effective against both gram-positive and gram-negative bacteria, including *Escherichia coli*. Its primary use is in veterinary medicine for the treatment of infections such as diarrhea (colibacillosis) in calves and swine caused or complicated by *E. coli*[1][4][5]. The mechanism of action involves competitive inhibition of the bacterial enzyme dihydropteroate synthase, thereby blocking dihydrofolic acid synthesis required for folic acid production and ultimately inhibiting bacterial growth[6][8]. Sulfachlorpyridazine is approved for veterinary use and may also be used to study metabolic pathways in microbiology research.

Other names
sulfachloropyridazinesulphachlorpyridazinesodium sulfachlorpyridazine monohydratesulfachlorpyridazine sodium
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sulfachlorpyridazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfachlorpyridazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call